查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1850564

兽医参考实验室市场：按动物类型、检测类型、技术、最终用户、疾病类型和样本类型 - 2025-2032 年全球预测

Veterinary Reference Laboratory Market by Animal Type, Test Type, Technology, End User, Disease Type, Sample Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，兽医参考实验室市场将成长 136.6 亿美元，复合年增长率为 14.20%。

主要市场统计数据
基准年2024年 47.2亿美元
预计2025年 53.9亿美元
预测年份：2032年 136.6亿美元
复合年增长率（%） 14.20%

介绍重点介绍技术进步、监管发展和商业压力如何重新定义兽医诊断实验室的优先事项

介绍部分描绘了快速发展的兽医诊断领域，其中技术创新、不断变化的监管环境以及动物健康的变化正在重塑实验室操作和临床决策。

在兽医实务和公共卫生领域，诊断正成为实证医疗的核心组成部分。实验室正在采用灵敏的分子检测法，以及更成熟的免疫检测和培养方法，以满足临床医生对更快、更准确结果的需求。同时，资源限制和供应链复杂性也对常规检测吞吐量提出了挑战。本概述将重点讨论如何重新配置​​诊断路径、相关人员如何调整实验室工作流程以及如何将诊断数据整合到疾病监测和预防保健计划中。本文也重点介绍了临床需求、实验室能力和外部压力如何相互作用，从而为兽医参考实验室创造商业机会和营运压力点。

后续章节将以此为基础，揭示市场的结构动态、监管和贸易影响、细分考虑、区域模式、竞争行为以及为领导者提供实用建议，帮助他们应对短期中断，同时使其组织保持持续的临床相关性和营运弹性。

对技术、监管和供应链融合力量的权威分析，这些力量正在加速动物诊断服务的结构性变革

本节探讨重塑兽医诊断服务的变革性变化，重点关注技术进步、政策变化和不断变化的相关人员期望，这些正在加速兽医诊断服务的成熟。

分子诊断已超越细分应用领域，成为临床检测的核心支柱，以前所未有的速度实现病原体特异性鑑定、抗药性分析和疫情追踪。同时，质谱和高通量免疫检测的进步扩展了实验室代谢和荷尔蒙评估的工具箱。法律规范正在适应这些技术，更新验证途径和品质要求，以促进标准化，但也使合规性变得更加复杂。在系统层面，诊断结果与实践管理和流行病学平台的数位整合正在改变临床决策，并支持人群层面的监测。此外，筹资策略正转向更具韧性的供应链，买家倾向于采用多供应商模式和本地製造伙伴关係关係，以减轻跨境中断的影响。总而言之，这些趋势正在加速服务提供者之间的整合，同时扩大专业实验室和技术整合商占领新临床利基市场的范围。最终的结果是建立一个更复杂、互联互通的诊断生态系统，奖励卓越的营运、数据管治以及与临床医生需求的策略协调。

深入回顾美国近期的关税调整如何重塑诊断实验室的采购、供应链弹性和营运规划

该分析检视了近期美国关税变化对兽医诊断业务、供应链和筹资策略的累积影响，同时对营运现实和缓解方法保持平衡的观点。

关税波动给支持常规和先进诊断方法的消耗品和资本设备都带来了成本压力。实验室正在透过重新评估其供应商组合、协商长期合约和实施库存优化措施来应对，以减少其受价格波动的影响。同时，一些实验室正在透过调整测试选单和优先内部开发试剂和通讯协定来减少对进口的依赖。对于设备采购，采购团队越来越多地将总拥有成本（包括关税风险和定序物流）纳入其资本论证模型。法规遵循考虑使供应商替代变得复杂，并鼓励在实施替代方案时采用更有条理的验证和交叉反应测试方法。重要的是，关税摩擦也推动了区域采购和与愿意共同开发客製化解决方案的国内製造商的策略伙伴关係。在这种环境下，实验室领导者必须平衡短期成本控制和长期投资，以保持临床能力和服务可靠性。

以整体、细分主导导向的观点，将动物类别、诊断方式、技术平台、最终用户需求、疾病重点和检体类型与实验室策略联繫起来

细分主导的洞察揭示了诊断需求和实验室设计如何因动物类别、测试方式、技术平台、最终用户类型、疾病重点和检体流程而异，为投资组合和产能规划提供了详细的图表。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 实施人工智慧驱动的诊断平台，用于跨多物种样本的通用感染疾病的早期检测
  • 采用液态生物检体技术监测小型和大型动物的癌症生物标记
  • 扩大多重PCR检测，实现同时检测牲畜多种感染疾病
  • 整合基于区块链的可追溯系统以确保兽医诊断中的样本来源
  • 利用元基因组定序全面监测兽医病原体中新出现的抗生素抗药性模式
  • 引入云端基础的数据分析仪表板，用于即时监测动物健康疫情

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 兽医参考实验室市场（依动物类型）

  • 大型动物
    • 牛
    • 马
  • 小宠物
    • 猫
    • 狗

9. 兽医参考实验室市场（依测试类型）

  • 微生物学
  • 分子诊断
  • 病理
  • 血清学

10. 兽医参考实验室市场（依技术）

  • 传统的
  • 免疫检测
  • 质谱法
  • 分子

第 11 章兽医参考实验室市场（按最终用户）

  • 学术的
  • 商业的
  • 政府

第十二章 兽医参考实验室市场（依疾病类型）

  • 遗传性疾病
  • 荷尔蒙
  • 感染疾病
    • 细菌
    • 真菌
    • 寄生虫
    • 病毒性的
  • 代谢

13. 兽医参考实验室市场（依样本类型）

  • 血
  • 屎
  • 棉花棒
  • 组织
  • 尿

14. 兽医参考实验室市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 15 章兽医参考实验室市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 兽医参考实验室市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • IDEXX Laboratories, Inc.
    • Zoetis Inc.
    • Covetrus, Inc.
    • Heska Corporation
    • Neogen Corporation
    • Eurofins Scientific SE
    • SYNLAB AG
Product Code: MRR-374DB5A06893

The Veterinary Reference Laboratory Market is projected to grow by USD 13.66 billion at a CAGR of 14.20% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.72 billion
Estimated Year [2025] USD 5.39 billion
Forecast Year [2032] USD 13.66 billion
CAGR (%) 14.20%

A focused introduction that sets the context for how technological advances, regulatory dynamics, and operational pressures are redefining veterinary diagnostic laboratory priorities

The introduction frames a rapidly evolving veterinary diagnostic landscape where technological innovation, shifting regulatory priorities, and changing patterns of animal health converge to reshape laboratory operations and clinical decision making.

Across veterinary practice and public health functions, diagnostics are increasingly central to evidence-based care. Laboratories are adopting high-sensitivity molecular assays alongside more established immunoassays and culture-based techniques to meet clinician demands for faster, more precise results. At the same time, resource constraints and supply chain complexity challenge routine testing throughput. This introductory overview sets the stage for a focused examination of how diagnostic pathways are being reconfigured, how stakeholders are adapting laboratory workflows, and how diagnostic data are being integrated into disease surveillance and preventive care programs. It also highlights the interplay between clinical needs, laboratory capabilities, and external pressures that create both opportunities and operational stress points for veterinary reference laboratories.

Subsequent sections build from this foundation to unpack structural market dynamics, regulatory and trade impacts, segmentation-driven insights, regional patterns, competitive behaviors, and practical recommendations for leaders seeking to navigate near-term disruptions while positioning their organizations for sustained clinical relevance and operational resilience.

An authoritative analysis of the converging technological, regulatory, and supply chain forces that are accelerating structural change across veterinary diagnostic services

This section examines transformative shifts reshaping veterinary diagnostic services, emphasizing technological progress, policy change, and evolving stakeholder expectations that together accelerate the sector's maturation.

Molecular diagnostics have moved beyond niche applications to become a core pillar of clinical testing, enabling pathogen-specific identification, resistance profiling, and outbreak tracing with unprecedented speed. Concurrently, advances in mass spectrometry and high-throughput immunoassays have expanded the laboratory toolbox for metabolic and hormonal assessments. Regulatory frameworks are adapting to these technologies with updated validation pathways and quality requirements that drive standardization but also increase compliance complexity. At the systems level, digital integration of diagnostic results into practice management and epidemiological platforms is changing the cadence of clinical decision making and supporting population-level surveillance. Moreover, procurement strategies are shifting toward resilient supply chains, with buyers favoring multi-supplier approaches and local manufacturing partnerships to mitigate cross-border disruptions. Taken together, these forces are accelerating consolidation among service providers while opening space for specialized laboratories and technology integrators to capture new clinical niches. The net effect is a more sophisticated, interconnected diagnostic ecosystem that rewards operational excellence, data governance, and strategic alignment with clinician needs.

A detailed review of how recent tariff adjustments in the United States are reshaping procurement, supply chain resilience, and operational planning for diagnostic laboratories

This analysis explores the cumulative effects of recent tariff changes in the United States on veterinary diagnostic operations, supply chains, and procurement strategies while preserving a balanced view of operational realities and mitigation approaches.

Tariff shifts have introduced cost pressure across both consumables and capital equipment that support routine and advanced diagnostic modalities. Laboratories have responded by re-evaluating supplier portfolios, negotiating longer-term contracts, and implementing inventory optimization measures to reduce exposure to price volatility. In parallel, some organizations are adjusting test menus and prioritizing in-house development of reagents and protocols to reduce dependency on imported inputs. For equipment acquisitions, procurement teams are increasingly factoring total cost of ownership, including tariff risk and servicing logistics, into capital justification models. Regulatory compliance considerations complicate supplier substitution, encouraging a methodical approach to validation and cross-reactivity testing when alternatives are introduced. Importantly, tariff-induced friction has also incentivized regional sourcing and strategic partnerships with domestic manufacturers willing to co-develop bespoke solutions. In this environment, laboratory leaders must balance short-term cost containment with long-term investments that preserve clinical capabilities and service reliability, recognizing that operational continuity remains essential for animal health care and public health surveillance.

A comprehensive segmentation-driven perspective that links animal categories, diagnostic modalities, technology platforms, end-user needs, disease focuses, and specimen types to laboratory strategy

Segmentation-driven insight reveals how diagnostic demand and laboratory design vary by animal category, test modality, technology platform, end-user type, disease focus, and sample stream, offering a granular map for portfolio and capability planning.

Based on animal type, analytical pathways diverge between Large Animals, which prioritize production and herd health considerations and are studied across Cattle and Horses, and Small Companion Animals, which prioritize individual clinical outcomes and are studied across Cats and Dogs. Based on test type, laboratory services span Microbiology, Molecular Diagnostics, Pathology, and Serology, each with distinct workflow, turnaround time, and quality control imperatives. Based on technology, choices range across Conventional methods, Immunoassay platforms, Mass Spectrometry approaches, and Molecular tools, shaping capital needs and staffing competencies. Based on end user, demand originates from Academic institutions, Commercial practices, and Government laboratories, each bringing different expectations for reporting, validation, and research collaboration. Based on disease type, diagnostics address Genetic Disorders, Hormonal conditions, Infectious Diseases, and Metabolic issues, with Infectious Diseases further studied across Bacterial, Fungal, Parasitic, and Viral categories that imply differing sample handling and biosafety standards. Based on sample type, analytical pipelines are calibrated for Blood, Feces, Swabs, Tissue, and Urine, with pre-analytic controls and transport logistics tailored to preserve analyte integrity. Integrating these segmentation lenses enables laboratory leaders to align test menus, instrument footprints, staffing models, and client engagement strategies with clinical demand and operational constraints.

A nuanced regional analysis highlighting how regulatory diversity, clinical adoption patterns, and supply chain structures uniquely shape laboratory operations across global territories

Regional patterns demonstrate distinct regulatory, supply, and clinical practice contexts that influence laboratory operations and strategic positioning across global markets.

In the Americas, diagnostic networks are increasingly consolidated, with a strong emphasis on integrated laboratory information systems and partnerships between clinical practices and centralized reference services; this region often leads in clinical adoption of advanced molecular assays and rapid-response capabilities. In Europe, Middle East & Africa, regulatory harmonization efforts and diverse public health priorities create a mosaic of laboratory requirements, where multilingual reporting, cross-border collaboration, and variable infrastructure levels demand flexible service models. In the Asia-Pacific region, rapid growth in pet ownership and intensifying livestock production are driving demand for scalable diagnostic solutions, while local manufacturing and innovative distribution channels are reshaping procurement dynamics. Each regional context carries its own talent pool considerations, reimbursement norms, and logistical challenges, suggesting that a one-size-fits-all approach to service design is likely to underperform. Instead, tailored regional strategies that account for regulatory timing, supply chain topology, and clinician expectations will better support sustainable expansion and quality outcomes.

An insightful overview of the strategic postures adopted by industry participants, from vertically integrated platforms to specialist service providers and collaborative innovation models

Competitive behaviors among leading companies illustrate how strategic choices around vertical integration, service breadth, and partnership models create differentiated value propositions in the diagnostic ecosystem.

Some firms are concentrating on building comprehensive end-to-end offerings that combine proprietary assays, instrument platforms, and managed services to create stickier customer relationships and predictable revenue streams. Others pursue a modular approach, focusing on specialty testing or technology-enabled services that integrate with third-party laboratory information systems to deliver flexibility for clinicians. Strategic alliances with academic centers and government programs continue to be important channels for validation studies and product adoption, particularly for novel molecular and genomic applications. Investment in quality systems, accreditation, and transparent clinical performance data serves as a key trust signal for clients that demand rigorous evidence of diagnostic reliability. Additionally, companies are increasingly leveraging data analytics and remote monitoring to offer value-added services such as test utilization reviews and population health insights. This competitive heterogeneity creates opportunities for both consolidation and niche specialization, with successful organizations combining technical excellence with strong client engagement and operational reliability.

Action-oriented guidance for laboratory leadership focused on workforce agility, procurement resilience, modular technology adoption, and evidence-driven partnerships to secure long-term operational strength

Actionable recommendations guide laboratory executives and industry leaders on prioritizing investments, workforce development, and supplier strategies to strengthen resilience and clinical relevance.

Leaders should invest in cross-trained laboratory personnel who can operate molecular instruments, mass spectrometers, and immunoassay platforms while maintaining strong quality assurance practices; such capability reduces bottlenecks and enhances flexibility during demand surges. Procurement strategies should emphasize supplier diversification, strategic stocking of critical reagents, and collaborative agreements with local manufacturers to reduce tariff and logistics exposure. From a technology standpoint, adopting modular, interoperable systems and standardized data exchange protocols improves scalability and eases integration with clinical practice management tools. Strategic partnerships with academic centers and public health agencies can accelerate validation pathways and expand the clinical evidence base for new assays. Finally, governance frameworks that prioritize data integrity, client communication, and transparent performance metrics will help build trust with clinicians and regulatory bodies, supporting sustained laboratory relevance amid evolving clinical and policy expectations.

A transparent and rigorous research methodology combining primary stakeholder engagement and targeted secondary evidence synthesis to produce defensible operational insights

The research methodology section describes the structured approach used to gather, validate, and synthesize qualitative and quantitative inputs from a broad range of stakeholders for a rigorous, reproducible analysis.

Primary research included in-depth interviews and structured consultations with laboratory directors, clinicians, procurement specialists, and regulatory advisors to capture frontline experience with diagnostic workflows, technology adoption, and supply chain challenges. Secondary sources comprised peer-reviewed literature, regulatory guidance documents, and industry reports to provide contextual grounding and to triangulate primary insights. Data synthesis employed thematic analysis to identify cross-cutting patterns and causal linkages, while validation rounds with subject-matter experts ensured that findings were operationally relevant and technically accurate. Attention was given to transparency in assumptions and to documenting methodological limitations, particularly where regional data heterogeneity required careful interpretation. The result is a defensible, practice-focused body of work that supports strategic decision making without overstating precision in areas where data are fragmented or rapidly evolving.

A strategic conclusion that crystallizes the essential operational and clinical imperatives laboratories must adopt to remain resilient, credible, and service-focused in a changing environment

The conclusion synthesizes the study's core implications for diagnostic strategy, operational resilience, and clinical impact, reinforcing the imperative for proactive leadership across laboratory networks.

Diagnostic services sit at the intersection of animal health, public health surveillance, and clinical care, and the sector's trajectory is shaped by technological innovation, regulatory evolution, and supply chain dynamics. Organizations that align capabilities with segmentation realities-matching test menus and platforms to animal type, disease focus, and sample workflows-are better positioned to deliver timely, actionable results. Strategic investments in workforce skills, interoperable technologies, and diversified procurement reduce operational fragility and enable laboratories to respond to episodic surges or supply disruptions. Collaborative relationships with academic, commercial, and governmental partners can accelerate method validation and broaden the evidence base for new assays. In closing, the path to sustained relevance depends on deliberate, evidence-based choices that balance near-term continuity with long-term capability building, ensuring that diagnostic services remain a reliable foundation for clinical decision making and disease prevention.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Implementation of AI-driven diagnostic platforms for early detection of zoonotic pathogens across multi-species samples
  • 5.2. Adoption of liquid biopsy techniques to monitor cancer biomarkers in small and large animal patients
  • 5.3. Expansion of multiplex PCR assays enabling simultaneous detection of multiple infectious diseases in livestock
  • 5.4. Integration of blockchain-based traceability systems to secure sample provenance in veterinary diagnostics
  • 5.5. Use of metagenomic sequencing for comprehensive surveillance of emerging antimicrobial resistance patterns in veterinary pathogens
  • 5.6. Deployment of cloud-based data analytics dashboards for real-time epidemiological monitoring of animal health outbreaks

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Reference Laboratory Market, by Animal Type

  • 8.1. Large Animals
    • 8.1.1. Cattle
    • 8.1.2. Horses
  • 8.2. Small Companion Animals
    • 8.2.1. Cats
    • 8.2.2. Dogs

9. Veterinary Reference Laboratory Market, by Test Type

  • 9.1. Microbiology
  • 9.2. Molecular Diagnostics
  • 9.3. Pathology
  • 9.4. Serology

10. Veterinary Reference Laboratory Market, by Technology

  • 10.1. Conventional
  • 10.2. Immunoassay
  • 10.3. Mass Spec
  • 10.4. Molecular

11. Veterinary Reference Laboratory Market, by End User

  • 11.1. Academic
  • 11.2. Commercial
  • 11.3. Government

12. Veterinary Reference Laboratory Market, by Disease Type

  • 12.1. Genetic Disorders
  • 12.2. Hormonal
  • 12.3. Infectious Diseases
    • 12.3.1. Bacterial
    • 12.3.2. Fungal
    • 12.3.3. Parasitic
    • 12.3.4. Viral
  • 12.4. Metabolic

13. Veterinary Reference Laboratory Market, by Sample Type

  • 13.1. Blood
  • 13.2. Feces
  • 13.3. Swabs
  • 13.4. Tissue
  • 13.5. Urine

14. Veterinary Reference Laboratory Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Veterinary Reference Laboratory Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Veterinary Reference Laboratory Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. IDEXX Laboratories, Inc.
    • 17.3.2. Zoetis Inc.
    • 17.3.3. Covetrus, Inc.
    • 17.3.4. Heska Corporation
    • 17.3.5. Neogen Corporation
    • 17.3.6. Eurofins Scientific S.E.
    • 17.3.7. SYNLAB AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. VETERINARY REFERENCE LABORATORY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. VETERINARY REFERENCE LABORATORY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VETERINARY REFERENCE LABORATORY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DOGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DOGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DOGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DOGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PATHOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PATHOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PATHOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PATHOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PATHOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SEROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SEROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SEROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SEROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SEROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SEROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MASS SPEC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MASS SPEC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MASS SPEC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MASS SPEC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MASS SPEC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MASS SPEC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ACADEMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ACADEMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ACADEMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COMMERCIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GOVERNMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GOVERNMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GOVERNMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORMONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORMONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORMONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORMONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORMONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORMONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BACTERIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FUNGAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FUNGAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FUNGAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FUNGAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FUNGAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FUNGAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PARASITIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PARASITIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PARASITIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PARASITIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PARASITIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PARASITIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY VIRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY VIRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY VIRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY VIRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY METABOLIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY METABOLIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY METABOLIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY METABOLIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY METABOLIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY METABOLIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FECES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FECES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FECES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FECES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FECES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FECES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SWABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SWABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SWABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SWABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SWABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SWABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY URINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY URINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY URINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY URINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY URINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2024